loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Namodenoson, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Namodenoson

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass

    Inke S.A: APIs manufacturing plant.

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    2D Structure
    1. Also known as: 2-cl-ib-meca, 163042-96-4, Namodenoson, Cl-ib-meca, Cf-102, Cf102
    Molecular Formula
    C18H18ClIN6O4
    Molecular Weight
    544.7  g/mol
    InChI Key
    IPSYPUKKXMNCNQ-PFHKOEEOSA-N
    FDA UNII
    Z07JR07J6C
    Namodenoson is an orally bioavailable, synthetic, highly selective adenosine A3 receptor (A3AR) agonist with potential antineoplastic activity. Namodenoson selectively binds to and activates the cell surface-expressed A3AR, deregulating Wnt and NF-kB signal transduction pathways downstream, which may result in apoptosis of A3AR-expressing tumor cells. A3AR, a G protein-coupled receptor, is highly expressed on the cell surfaces of various solid tumor cell types, including hepatocellular carcinoma (HCC) cells, and plays an important role in cellular proliferation.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (2S,3S,4R,5R)-5-[2-chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N-methyloxolane-2-carboxamide
    2.1.2 InChI
    InChI=1S/C18H18ClIN6O4/c1-21-16(29)13-11(27)12(28)17(30-13)26-7-23-10-14(24-18(19)25-15(10)26)22-6-8-3-2-4-9(20)5-8/h2-5,7,11-13,17,27-28H,6H2,1H3,(H,21,29)(H,22,24,25)/t11-,12+,13-,17+/m0/s1
    2.1.3 InChI Key
    IPSYPUKKXMNCNQ-PFHKOEEOSA-N
    2.1.4 Canonical SMILES
    CNC(=O)C1C(C(C(O1)N2C=NC3=C(N=C(N=C32)Cl)NCC4=CC(=CC=C4)I)O)O
    2.1.5 Isomeric SMILES
    CNC(=O)[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=C(N=C32)Cl)NCC4=CC(=CC=C4)I)O)O
    2.2 Other Identifiers
    2.2.1 UNII
    Z07JR07J6C
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 2-chloro-n(6)-(3-iodobenzyl)-9-(5-(methylcarbamoyl)-beta-d-ribofuranosyl)adenine

    2. 2-chloro-n(6)-(3-iodobenzyl)adenosine-5'-n-methyluronamide

    3. 2-chloro-n6-(3-iodobenzyl)adenosine-5'-n-methylcarboxamide

    4. 2-cl-ib-meca

    5. C-ibza-mu

    6. Cf102 Compound

    2.3.2 Depositor-Supplied Synonyms

    1. 2-cl-ib-meca

    2. 163042-96-4

    3. Namodenoson

    4. Cl-ib-meca

    5. Cf-102

    6. Cf102

    7. C-ibza-mu

    8. (2s,3s,4r,5r)-5-(2-chloro-6-((3-iodobenzyl)amino)-9h-purin-9-yl)-3,4-dihydroxy-n-methyltetrahydrofuran-2-carboxamide

    9. Ci-ib-meca

    10. 2-chloro-n(6)-(3-iodobenzyl)adenosine-5'-n-methyluronamide

    11. Namodenoson [usan]

    12. 2cl-ib-meca

    13. (2s,3s,4r,5r)-5-[2-chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-n-methyloxolane-2-carboxamide

    14. Chembl431733

    15. Z07jr07j6c

    16. 1-[2-chloro-6-[[(3-iodophenyl)methyl]amino]-9h-purin-9-yl]-1-deoxy-n-methyl-beta-d-ribofuranuronamide

    17. Unii-z07jr07j6c

    18. 1-(2-chloro-6-(((3-iodophenyl)methyl)amino)-9h-purin-9-yl)-1-deoxy-n-methyl-beta-d-ribofuranuronamide

    19. Beta-d-ribofuranuronamide, 1-(2-chloro-6-(((3-iodophenyl)methyl)amino)-9h-purin-9-yl)-1-deoxy-n-methyl-

    20. Beta-d-ribofuranuronamide, 1-[2-chloro-6-[[(3-iodophenyl)methyl]amino]-9h-purin-9-yl]-1-deoxy-n-methyl-

    21. Cf 102

    22. 2-chloro-n6-(3-iodobenzyl)adenosine-5'-n-methylcarboxamide

    23. Namodenoson [inn]

    24. Namodenoson (cf-102)

    25. Namodenoson (usan/inn)

    26. C1-ib-meca

    27. 2-chloro-n(6)-(3-iodobenzyl)-9-(5-(methylcarbamoyl)-beta-d-ribofuranosyl)adenine

    28. Gtpl457

    29. Namodenoson [who-dd]

    30. Mls002153535

    31. Schembl1170028

    32. Bdbm21221

    33. 2-chloro-n6-(3-iodobenzyl)adenosine-5'-n-methyluronamide

    34. Cf-102;2-cl-ib-meca

    35. Dtxsid80167504

    36. Hms2235l10

    37. Hms3412i05

    38. Hms3676i05

    39. Cf-102(2-cl-ib-meca)

    40. Ex-a2882

    41. Zinc3995845

    42. Mfcd01861178

    43. Akos022181265

    44. Am84557

    45. Cs-5932

    46. Db12885

    47. Ncgc00025001-02

    48. Ac-27390

    49. Ds-16397

    50. Hy-12365

    51. Smr001230862

    52. Chloro-ib-meca, Solid, >=98% (hplc)

    53. B6597

    54. C3601

    55. S0498

    56. D11128

    57. P10208

    58. A848899

    59. J-009992

    60. Q27076097

    61. 2-chloro-n6-(3-iodobenzyl)adenosine-5-n-methylcarboxamide

    62. (2s,3s,4r,5r)-5-(2-chloro-6-(3-iodobenzylamino)-9h-purin-9-yl)-3,4-dihydroxy-n-methyltetrahydrofuran-2-carboxamide

    63. (2s,3s,4r,5r)-5-(2-chloro-6-{[(3-iodophenyl)methyl]amino}-9h-purin-9-yl)-3,4-dihydroxy-n-methyloxolane-2-carboxamide

    64. (2s,3s,4r,5r)-5-(6-(3-iodobenzylamino)-2-chloro-9h-purin-9-yl)-3,4-dihydroxy-n-methyl-tetrahydrofuran-2-carboxamide

    65. .beta.-d-ribofuranuronamide, 1-(2-chloro-6-(((3-iodophenyl)methyl)amino)-9h-purin-9-yl)-1-deoxy-n-methyl-

    66. 1-(2-chloro-6-(((3-iodophenyl)methyl)amino)-9h-purin-9-yl)-1-deoxy-n-methyl-.beta.-d-ribofuranuronamide

    67. 1-[2-chloro-6-[[(3-iodophenyl)methyl]amino]-9h-purin-9-yl]-1-deoxy-n-methyl-?-d-ribofuranuronamide

    68. 1-[2-chloro-6-[[(3-iodophenyl)methyl]amino]-9h-purin-9-yl]-1-deoxy-n-methyl-beta-d-ribofuranuronamide;2-chloro-n6-(3-iodobenzyl)adenosine-5'-n-methyluronamide;2-cl-ib-meca;2-cl-ib-meca

    2.4 Create Date
    2005-08-08
    3 Chemical and Physical Properties
    Molecular Weight 544.7 g/mol
    Molecular Formula C18H18ClIN6O4
    XLogP31.9
    Hydrogen Bond Donor Count4
    Hydrogen Bond Acceptor Count8
    Rotatable Bond Count5
    Exact Mass544.01228 g/mol
    Monoisotopic Mass544.01228 g/mol
    Topological Polar Surface Area134 Ų
    Heavy Atom Count30
    Formal Charge0
    Complexity623
    Isotope Atom Count0
    Defined Atom Stereocenter Count4
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Purinergic P1 Receptor Agonists

    Compounds that bind to and stimulate PURINERGIC P1 RECEPTORS. (See all compounds classified as Purinergic P1 Receptor Agonists.)

    Post Enquiry
    POST ENQUIRY